Article Versions Notes

Zhang X-Y, Zhang Y-K, Wang Y-J, Gupta P, Zeng L, Xu M, Wang X-Q, Yang D-H, Chen Z-S. Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells. Molecules. 2016; 21(9):1236. https://doi.org/10.3390/molecules21091236

Zhang, Xiao-Yu, Yun-Kai Zhang, Yi-Jun Wang, Pranav Gupta, Leli Zeng, Megan Xu, Xiu-Qi Wang, Dong-Hua Yang, and Zhe-Sheng Chen. 2016. "Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells" Molecules 21, no. 9: 1236. https://doi.org/10.3390/molecules21091236

Zhang, X. -Y., Zhang, Y. -K., Wang, Y. -J., Gupta, P., Zeng, L., Xu, M., Wang, X. -Q., Yang, D. -H., & Chen, Z. -S. (2016). Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells. Molecules, 21(9), 1236. https://doi.org/10.3390/molecules21091236